Provided by Tiger Trade Technology Pte. Ltd.

Aethlon Medical

2.22
-0.0099-0.44%
Volume:17.62K
Turnover:39.20K
Market Cap:2.16M
PE:-0.04
High:2.32
Open:2.32
Low:2.17
Close:2.23
52wk High:63.37
52wk Low:2.08
Shares:971.87K
Float Shares:967.50K
Volume Ratio:0.57
T/O Rate:1.82%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-56.6915
EPS(LYR):-85.7749
ROE:-191.39%
ROA:-54.79%
PB:0.38
PE(LYR):-0.03

Loading ...

Company Profile

Company Name:
Aethlon Medical
Exchange:
NASDAQ
Establishment Date:
1984
Employees:
9
Office Location:
11555 Sorrento Valley Road,Suite 203,San Diego,California,United States
Zip Code:
92121
Fax:
619 941 0361
Introduction:
Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system. The company was founded in 1999 and is based in San Diego, California.

Directors

Name
Position
Edward G. Broenniman
Chairman and Independent Director
James B. Frakes
Chief Executive Officer and Chief Financial Officer and Director
Angela Rossetti
Independent Director
Chetan S. Shah
Independent Director
Nicolas Gikakis
Independent Director

Shareholders

Name
Position
James B. Frakes
Chief Executive Officer and Chief Financial Officer and Director
Steven P. LaRosa
Chief Medical Officer